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Background: Schistosomiasis is a parasitic infection that continues to be a major public health problem in many
developing countries being responsible for an estimated burden of at least 1.4 million disability-adjusted life years
(DALYs) in Africa alone. Importantly, morbidity due to schistosomiasis has been greatly reduced in some parts of
the world, including Zanzibar. The Zanzibar government is now committed to eliminate urogenital schistosomiasis.
Over the next 3–5 years, the whole at-risk population will be administered praziquantel (40 mg/kg) biannually.
Additionally, snail control and behaviour change interventions will be implemented in selected communities and
the outcomes and impact measured in a randomized intervention trial.
Methods/Design: In this 5-year research study, on both Unguja and Pemba islands, urogenital schistosomiasis will
be assessed in 45 communities with urine filtration and reagent strips in 4,500 schoolchildren aged 9–12 years
annually, and in 4,500 first-year schoolchildren and 2,250 adults in years 1 and 5. Additionally, from first-year
schoolchildren, a finger-prick blood sample will be collected and examined for Schistosoma haematobium infection
biomarkers. Changes in prevalence and infection intensity will be assessed annually. Among the 45 communities, 15
were randomized for biannual snail control with niclosamide, in concordance with preventive chemotherapy
campaigns. The reduction of Bulinus globosus snail populations and S. haematobium-infected snails will be
investigated. In 15 other communities, interventions triggering behaviour change have been designed and will be
implemented in collaboration with the community. A change in knowledge, attitudes and practices will be
assessed annually through focus group discussions and in-depth interviews with schoolchildren, teachers, parents
and community leaders. In all 45 communities, changes in the health system, water and sanitation infrastructure
will be annually tracked by standardized questionnaire-interviews with community leaders. Additional issues
potentially impacting on study outcomes and all incurring costs will be recordedand monitored longitudinally.
Discussion: Elimination of schistosomiasis has become a priority on the agenda of the Zanzibar government and
the international community. Our study will contribute to identifying what, in addition to preventive chemotherapy,
needs to be done to prevent, control, and ultimately eliminate schistosomiasis, and to draw lessons for current and
future schistosomiasis elimination programmes in Africa and elsewhere.
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Burden and transmission of schistosomiasis, with focus
on Schistosoma haematobium infection in Zanzibar
Schistosomiasis is a group of diseases caused by parasitic
worms of the genus Schistosoma. These blood-dwelling
flukes have a complicated life cycle involving freshwater
snail intermediate hosts and transmission of the parasite
is governed by social-ecological systems and intimately
linked with conditions of poverty [1,2]. More than 200
million people are infected with more than 95% of the
infections concentrated in Africa [3-5]. The global bur-
den due to schistosomiasis is currently estimated at 1.7-
4.5 million disability-adjusted life years (DALYs) [2,6,7].
Schistosomiasis predominantly occurs in tropical and
sub-tropical areas, but the disease is also seen in specia-
lized travel clinics in Europe and North America among
migrants and returning travellers [8,9]. Schistosomiasis
can cause acute illness, but its main public health impact
is due to chronic infection, including increased risk for
anaemia, growth stunting and under-nutrition in
affected populations, as well as exacerbation of co-
infections and impairment of cognitive development and
work capacity [10]. Depending on the species of Schisto-
soma, the liver, intestine, spleen, lungs and urogenital
system are affected, which can cause serious health pro-
blems in later life [10]. For example, chronic infection
with Schistosoma haematobium is associated with blad-
der cancer, and might account for up to 30% of all can-
cer cases in some endemic regions [11,12].
Humans become infected with S. haematobium when
they wade, swim or bathe in water, inhabited by compat-
ible intermediate snail hosts, previously contaminated by
human urine containing parasite eggs. The adult schisto-
somes live as paired male and female worms in the peri-
vesical venous plexus of their human host. Eggs
produced by female worms get trapped in the tissues
and can lead to inflammatory and obstructive disease in
the urogenital system [3]. Eggs that pass through the
bladder wall are voided in urine. If urination occurs in
freshwater, the parasite eggs will hatch in the water and
release miracidia (a free swimming larval stage), which
subsequently infect the specific intermediate host snails.
In Zanzibar, the only intermediate host snail for S. hae-
matobium is Bulinus globosus [13]. In the snail, asexual
reproduction takes place and 4–6 weeks after infection,the snail starts to shed cercariae, the human infective lar-
val stage, into the water. Importantly, a single snail can
shed thousands of cercariae over its life-time. On
locating a human host, cercariae penetrate the skin and,
after migrating via the lungs to the liver develop, within
9–10 weeks, into adult separate sex worms. These worms
pair up, and on average, live and produce eggs for 3–5
years. Many eggs leave the body via the excreta, but many
more become trapped in the tissues causing an inflamma-
tory reaction that leads to morbidity [3,14,15].
In Zanzibar, the population is at risk of infection with
only S. haematobium [13,16], the schistosome species
that affects the bladder, genital tract and urethras
[17-20], causing urogenital schistosomiasis. The highest
prevalence of S. haematobium infection is found among
school-aged children on both islands, Unguja and Pemba
[21-25]. Previous research has shown that visible haema-
turia, microhaematuria and urinary and genital tract
pathology are associated with infection, particularly
heavy intensity infections [24-27].
Control of schistosomiasis with focus on efforts in Zanzibar
To interrupt the life cycle of S. haematobium, there are
four main strategies: (i) kill the worms in humans, by
anthelminthic drugs; (ii) kill the intermediate host snails,
including those carrying intramolluscan parasites, by
chemical (i.e. molluscicides) or biological control agents
(e.g. competitor snails and fish); (iii) stop people infect-
ing snails, by convincing them not to urinate into open
freshwater bodies; and (iv) stop cercariae infecting man,
by keeping people out of infested water bodies [28,29].
The current global strategy to control morbidity due
to schistosomiasis is preventive chemotherapy that is the
regular administration of the anthelminthic drug prazi-
quantel to at-risk populations (e.g. school-aged children)
without prior diagnosis [30]. In the frame of preventive
chemotherapy programmes in Zanzibar, praziquantel has
been administered to school-aged children on both
islands since 1994 by multiple rounds of treatment de-
pending on the availability of external funds [23,24,31-33].
As a result, the prevalence and intensity of S. haematobium
infection in school-aged children in Unguja and Pemba
decreased considerably. For example, in Unguja, while a
prevalence of >50% was recorded in the early 1980s, it has
dropped to <10% in 2006 [23,34,35]. Hence, morbidity
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survey carried out in March 2011 in 24 schools on each is-
land, the overall prevalence of S. haematobium was 8% in
Unguja and 15% in Pemba.
Current initiatives for schistosomiasis control in Zanzibar
In mid-2010, the Zanzibar government expressed commit-
ment to eliminate urogenital schistosomiasis on the
islands of Unguja and Pemba. As backbone for this com-
mitment the Zanzibar Neglected Tropical Disease (NTD)
Programme will be implementing its “3-year comprehen-
sive strategic plan to combat neglected tropical diseases in
Zanzibar 2009/2011” [36], referred to as the “National
Plan”. It calls for preventive chemotherapy using prazi-
quantel, accompanied by health education and community
mobilization activities to consolidate and enhance the im-
pact of preventive chemotherapy. The National Plan is fo-
cusing on the districts, and zones within districts, where
urogenital schistosomiasis is known to be endemic.
In support of the National Plan, the World Health
Organization (WHO) has agreed to supply sufficient
quantities of praziquantel to ensure repeated rounds of
preventive chemotherapy and the Schistosomiasis Con-
trol Initiative (SCI) will assist with the drug intervention
at a large scale. WHO and SCI have long histories of
working with the Zanzibar Ministry of Health (MoH) in
their fight against schistosomiasis and soil-transmitted
helminthiasis [18,37].
An international consortium, called Zanzibar Elimination
of Schistosomiasis Transmission (ZEST), is committed to
assisting the government of Zanzibar in its efforts to elim-
inate urogenital schistosomiasis. This consortium includes
the Zanzibar MoH, including the Zanzibar NTD Control
Programme, the Public Health Laboratory - Ivo de Carneri
(PHL-IdC) Pemba, Zanzibar government agencies, WHO,
SCI, the Natural History Museum (NHM) in London, the
Swiss Tropical and Public Health Institute (Swiss TPH) in
Basel, the London School of Hygiene and Tropical
Medicine (LSHTM), the University of New Mexico and the
Schistosomiasis Consortium for Operational Research and
Evaluation (SCORE) based at the University of Georgia,
with additional groups expected to join as the efforts
progress. Within the ZEST project, the emphasis will shift
from morbidity control to comparative methods of trans-
mission control and local elimination of urogenital schisto-
somiasis. In addition to measuring the outcomes of this
project, thorough documentation of the process, including
lessons learned, will be crucial so that schistosomiasis
control and elimination programmes implemented else-
where can benefit from the ZEST experiences.
Research for schistosomiasis elimination in Zanzibar
SCORE was established in December 2008 to address
operational research questions pertaining to gaining andsustaining control of schistosomiasis, and to establish
the proof-of-concept that local elimination is feasible.
SCORE is funded through a 5-year grant by the Bill &
Melinda Gates Foundation awarded to the University of
Georgia Research Foundation (UGARF). The goal of
SCORE is to provide pragmatic answers that will help
current and future schistosomiasis control programme
managers to more efficiently control the disease more
efficiently. This includes learning which approaches need
to be pursued for controlling and eliminating schisto-
somiasis, as well as developing and validating new tools
and strategies. SCORE’s vision is that the work will in-
form efforts to gain control of schistosomiasis in high-
prevalence areas, sustain control and move towards
elimination in areas of moderate prevalence, and ultim-
ately eliminate schistosomiasis in areas of low
endemicity.
Increased use of praziquantel through preventive
chemotherapy and availability of treatments for those in
need will be central to the success of the National Plan
to control and eliminate schistosomiasis. At the same
time, increased efforts are required to reduce transmis-
sion of the disease. Layered onto the implementation of
the National Plan by the Zanzibar government, SCORE,
under the umbrella of the ZEST partners, will simultan-
eously study and implement additional measures of
schistosomiasis control/elimination.
Three promising interventions were discussed at ZEST
meetings in Zanzibar in 2011 as possible add-ons to pre-
ventive chemotherapy to be implemented as part of the
National Plan. These are: (i) water and sanitation
changes; (ii) snail control; and (iii) human behaviour
change interventions that could interrupt the transmis-
sion cycle of S. haematobium. The Zanzibar Water
Authority (ZAWA) has funding to provide piped water
and potentially improved sanitation, but such interven-
tions will take considerable time and effort and are
unlikely to make widespread progress within the time-
frame of ZEST. Therefore, the SCORE study presented
here will focus on evaluating the impact of snail control
using the molluscicide niclosamide and environmental
management and on a community-informed behaviour
change intervention on rates and success of efforts to
eliminate schistosomiasis in Zanzibar, in parallel with
the National Plan.
Goal, aims and objectives
The goal of this project is to provide an evidence-base
for programme decisions about schistosomiasis elimin-
ation, not only for the Zanzibar NTD Control
Programme, but also for other settings in Africa and
elsewhere that aim to eliminate schistosomiasis. The
study will be implemented on Unguja and Pemba
islands and will compare snail control and behaviour
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ventive chemotherapy in three study arms, each con-
sisting of 15 communities (shehias). Hence the study
involves a total of 45 study communities on each is-
land. The following aims and specific objectives are
related to this goal.
Aims
1. Eliminate schistosomiasis as a public health problem*
on Unguja in 3 years and interrupt transmission in 5
years.
2. Control schistosomiasis throughout Pemba (prevalence
<10% in school-aged children) in 3 years and eliminate
it as a public health problem* in 5 years.
3. To identify effective behaviour change strategies with
an understanding of the associated costs, motivators,
triggers and barriers associated with behaviour
change interventions.
4. To identify effective snail control strategies with an
understanding of the associated costs, motivators,
triggers and barriers associated with snail control
interventions.
* Eliminate schistosomiasis as a public health prob-
lem is defined: "Reduction of Schistosoma prevalence
to <1% heavy infections based upon direct egg-
detection methods in the school-aged population;
continued intervention measures are required to pre-
vent resurgence of transmission" as in Rollinson et al.
2012 [29].
Specific objectives, activities and milestones
1. To assess annually the reduction in prevalence and
intensity of S. haematobium infection according to
standardized, quality-controlled methods (i.e. urine
filtration and reagent strip testing) in schoolchildren
aged 9–12 years within and between each study arm
from year 1 to year 5.
2. To assess the reduction in the prevalence and intensity
of S. haematobium infection as measured by urine
filtration and reagent strip testing in adults in year 1
and in year 5 within and between each study arm.
3. To assess the reduction in the prevalence and intensity
of S. haematobium infection as measured by urine
filtration and reagent strip testing in first-year
schoolchildren in year 1 and in year 5 within and
between each study arm.
4. To assess the difference in the sero-prevalence of
S. haematobium infection in first-year schoolchildren
after 4 years of control within and between each
study arm.5. To assess annually changes in knowledge on
S. haematobium transmission and the impact of
change of behaviour on transmission.
6. To assess the impact of niclosamide on the presence
of B. globosus in freshwater ponds and rivers.
7. To test and evaluate recently developed methods for
the diagnosis of S. haematobium infections (such as:
enzyme linked immuno-sorbent assay (ELISA) for
assessment of antibody levels in blood; polymerase
chain reaction (PCR) for DNA detection in urine)
for their sensitivity, specificity and feasibility for
elimination programmes.
8. To create, test and validate mathematical models
for the prediction of S. haematobium prevalence
after control interventions (to be developed with
external partners).
Methods/Design
Study area and population
The zanzibar archipelago is part of the United Republic
of Tanzania and consists of the two main islands, Unguja
and Pemba [38], as well as a few much smaller islands.
There are two annual wet seasons: the Masika rains
from the south lasting usually from March to June, and
the Vuli rains from north-east occurring from October
to November. The average annual temperature ranges
between 23°C and 32°C. The estimated total resident
population for Unguja and Pemba was 773,234 and
511,576 inhabitants, respectively, in 2010 [39]. Islam is
the predominant religion [40]. The main economic activ-
ities include seawater fishing and cash crop production
(e.g. coconuts, cloves, chillies, copra and seaweed). Tour-
ism is of growing importance, since the islands offer a
host of historical and natural attractions [39].
Both islands are divided into large administrative areas
(i.e. districts). The districts are sub-divided into smaller
administrative units (i.e. shehias). Unguja consists of six
districts (North A, North B, Central, West, South and
Urban) and a total of 203 shehias. Pemba consists of
four districts (Micheweni, Wete, Chake and Mkoani),
subdivided into 88 shehias. In Unguja, schistosomiasis is
endemic in districts North A, North B, Central, West
and a part of the Urban district (entitled “Zone C” for
the operational ease of preventive chemotherapy distri-
bution), whereas all four districts of Pemba are endemic.
The schistosome-endemic areas will be targeted for pre-
ventive chemotherapy within the National Plan.
Interventions in the frame of SCORE and the National
Plan
The SCORE research study is designed as a randomized
trial to be layered on the planned preventive chemother-
apy campaigns to be conducted by the Zanzibar MoH.
The trial will have three study arms, each comprising 15
Figure 1 Study arms to assess the impact of different S. haematobium control interventions in Zanzibar. In a randomized intervention
trial with three study arms we will compare the impact of (i) praziquantel administration as implemented according to the National Plan of the
Zanzibar government, (ii) behaviour change interventions in addition to praziquantel administration and (iii) snail control in addition to
praziquantel administration on S. haematobium infection prevalences and intensities in Zanzibar (Unguja and Pemba islands). Each study arm
comprises 15 communities; hence, a total of 45 communities per island is surveyed. The number of study participants per study arm and
community is given in Figure 1.
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be included into the study. The three study arms are
designed as follows (Figure 1):
i) Implementation of the National Plan of the
Zanzibar government (preventive chemotherapy,
health education and community mobilization
focused on preventive chemotherapy).
ii) Implementation of the National Plan plus
targeted snail control.
iii) Implementation of the National Plan plus an intensive
behavioural intervention aimed at reducing
S. haematobium transmission.
Preventive chemotherapy in the frame of the National Plan
In the frame of the National Plan of the Zanzibar MoH,
preventive chemotherapy with praziquantel (40 mg/kg
using a dose pole) [41] against schistosomiasis and alben-
dazole (400 mg) against soil-transmitted helminthiasis will
be conducted twice each year, at 6-month intervals to all
children aged >2 years and all adults throughout the
islands. Severely sick people and pregnant women will be
excluded from preventive chemotherapy interventions.
However, presumptive treatment of pregnant women at
any stage of pregnancy will be implemented at mother
and child health (MCH) facilities, once in pregnancy, in all
the areas where schistosomiasis is transmitted.
The anthelminthic drugs for the preventive chemo-
therapy campaigns will be donated by WHO, whereas
SCI will financially support the implementation of drug
delivery. In addition to preventive chemotherapy, the
National Plan will promote health education and com-
munity mobilization campaigns.Snail control
B. globosus is the only intermediate host snail for S. hae-
matobium in Zanzibar and occurs commonly in a variety
of temporary and permanent habitats on Pemba and
Unguja [13]. Snail populations can be reduced either indir-
ectly by the destruction of their natural habitat, for
example by the removal of vegetation and debris from riv-
erbanks (environmental management), or directly by the
use of a molluscicide (chemical control). Environmental
management and mollusciciding represent important,
well-tried and effective tools to supplement preventive
chemotherapy against schistosomiasis [29,42,43]. The
molluscicide niclosamide has been recommended by
WHO to control human schistosomiasis [44-46]. It has
been applied earlier on Unguja in a study for the control
of schistosomiasis in the early 1980s [35], and has been
widely and effectively used for snail control in schistosom-
iasis control programmes in Morocco, Egypt and the
People’s Republic of China [47-50]. Moreover, niclosamide
70% wettable powder (WP) was tested in a pilot study in
Zanzibar in June-August 2011, preceding the study pro-
posed here.
In the randomly selected shehias of the current study,
niclosamide 70% WP will be applied to open water bod-
ies (slow flowing rivers, ponds and lakes) in concordance
with preventive chemotherapy. Since, the optimum time
for administering praziquantel is when the snail popula-
tions are absent and there is no risk of re-infection for
the treated population, mollusciciding is most effective if
applied immediately before a pre-planned chemotherapy
campaign to avoid immediate re-infection [28]. Areas
where humans are in regular contact with open fresh-
water bodies (e.g. for washing or bathing) in the selected
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70% WP in the months preceding preventive chemother-
apy in Zanzibar, aiming for two applications per year.
Before each intervention, all involved shehas (commu-
nity leaders) and community members will be informed
about the purpose of the studies and their concerns and
suggestions will be taken into consideration. Since snails
often lay eggs on rubbish in the rivers and ponds, the
community members will be encouraged to engage in
the clearance of vegetation and rubbish from open water
bodies; especially from potential transmission sites
where humans have regular water contact. Full safety
briefings will be required.
Behaviour change interventions
School-aged children who live in S. haematobium-
endemic areas are usually at the highest risk of becom-
ing infected and are most likely to be involved in trans-
mitting the disease, because they tend to spend time
swimming or playing in open water bodies that may
contain infected snails and because children have no or
limited protective immunity [51-54]. Adults are also at
risk of infection through bathing or washing clothes in
contaminated water or through occupational exposures
(e.g. fishing, rice farming and car washing) [40,55].
Health communication taking into account local know-
ledge, attitudes and practices and the integration of
communities in priority settings, decision making and
planning of schistosomiasis control interventions, will be
essential to achieve a change in behaviour [56].
The behaviours we believe most important to modify
in order to reduce schistosomiasis transmission in
Zanzibar are (i) children urinating in streams and ponds
and (ii) children playing, swimming and washing laundry
in the same streams and ponds. The urination behaviour
is particularly difficult to target because it is not observ-
able, and children with schistosomiasis may have
increased urgency and difficulty in restraining urination
because of bladder irritation from the parasite. Addition-
ally, with little else to do, rivers and ponds are a source
of recreation for children.
The behavioural intervention is being guided by
human-centred design (HCD) processes and techniques
[57]. This process starts with a specific challenge such as
the prevention of children urinating in rivers and ponds.
In partnership with the community we explore commu-
nity knowledge, beliefs, current practices and social
norms related to the challenge through formative quali-
tative methods. The resulting findings are shared with
the community and together through a participatory
process a behavioural intervention is designed and
implemented as concrete and tangible solutions. This
process helped to identify cultural norms around urin-
ation in freshwater bodies and messages, activities andapproaches that might be useful to change children’s be-
haviour in Zanzibar. In addition we identified alternative
structural solutions and replacement behaviours to urin-
ating in the water that might be acceptable in
Zanzibar, as well as best channels and approaches for
communications [58]. Behavioural interventions based
on formative findings and the participatory work of the
community are being designed to raise awareness of
schistosomiasis transmission, diagnosis, treatment and
prevention and to influence the adoption of new beha-
viours by: (i) training teachers, coaches and students in
local primary schools; (ii) training teachers and students
in religious schools; (iii) designing and installing locally
produced male and female urinals at targeted water hot-
spots where children congregate; (iv) providing alterna-
tive play activities and play structures for children; and
(v) providing washing platforms at designated tap water
sources and areas a short distance from local washing
water sources.
Justification of the number of participants
With regard to the goal and aims of the SCORE study,
the comparison of outcomes between the three interven-
tion arms will document benefits of interventions added
to preventive chemotherapy. However, due to the overall
low S. haematobium prevalence in Unguja (8% in
school-aged children, as determined in 24 schools sur-
veyed in March 2011) and the estimated further decrease
in prevalence due to biannual treatment in the coming 3
years, the difference attributed to additional interven-
tions could be very small. Hence, to reach a desired
power of 80% in our randomized trial, we would need a
sample size of clusters (i.e. shehias) that exceeds the
total number of shehias in schistosomiasis-endemic set-
tings in Unguja and Pemba and a sample size of partici-
pants that is not logistically feasible. The choice of 15
shehias per intervention arm per island, and the number
of people to be tested (per island: 4,500 children aged 9–
12 years annually, 4,500 first-year schoolchildren in years
1 and 5 and 2,250 adults in years 1 and 5) is a com-
promise between what is optimal and what is practically
achievable.
Selection and randomization of study shehias
and participants
Eligibility and randomization of shehias
Unguja and Pemba are divided into 203 and 88 shehias,
respectively. The following exclusion criteria were
applied. First, in Unguja, all shehias with no endemic
schistosomiasis according to expert opinion (n=104) and
in Pemba all shehias without a stream indicated on an
aerial photography (n=13) were excluded. Second, all
shehias without a primary school were excluded
(Unguja: n=43; Pemba: n=23). Third, if a shehia had
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pupil numbers was excluded. Fourth, all shehias with
schools that were attended by fewer than 200 children in
2008 (most recent available data) were excluded (Pemba:
n=1). Primary schools in Zanzibar include school grades
1–7, consisting of children mainly aged between 7 and
13 years. Hence, we anticipate that, in a school attended
by at least 200 children in 2008, there are at least 100
children aged 9–12 years that can be enrolled for the
current study. Fifth, one shehia in Unguja and one she-
hia in Pemba were excluded as the indicated school was
not located in the same shehia. Adhering to these inclu-
sion and exclusion criteria resulted in 45 eligible shehias
in Unguja and 50 eligible shehias in Pemba.
For the random selection and allocation of 45 shehias
both in Unguja and Pemba to one of the three interven-
tion arms, in a first step, all eligible shehias having parti-
cipated in the annual 24-school surveys formerly
conducted by the Piga vita Kichocho programme [23]
(Unguja: n=13; Pemba: n=17) were included in a
computer-based randomization to one of the three study
arms. In a second step, out of the remaining 33 shehias
in Pemba, 28 were randomly selected to be part of the
study. In a third step, the 32 shehias in Unguja and the
28 shehias in Pemba were randomized to one of the
three study arms. Although the randomization may have
resulted in differences in the starting prevalence of
S. haematobium infection or other factors among study
arms, we did not re-randomize. Figure 2 shows the dis-
tribution of shehias to each of the three study arms in
Unguja and Pemba.Eligibility and randomization of schoolchildren
In years 1 to 5 of the study, all schoolchildren aged
9–12 years and in years 1 and 5 additionally all
first-year schoolchildren are eligible to participate in
the study. For the respective surveys, (i) 130 children
aged 9–12 years and (ii) 130 first-year schoolchildren
will be randomly selected for urine collection and
additional finger-prick blood collection for first-year
schoolchildren. For this purpose, all eligible children
will line up, in separate lines for boys and girls and
school class. Subsequently, we will systematically se-
lect each third child in the lines to be included in
the study. This procedure will be continued until we
reach a total of 130 selected children, accounting for
a 20% drop-out with the final aim to sample 100
children aged 9–12 years and 100 first-year school-
children. We anticipate to collect each year 9,000
urine samples from 9-12-year-old children and 9,000
urine and finger-prick blood samples from first-year
schoolchildren in years 1 and 5 on each of the two
islands.Eligibility and randomization of adults from communities
All adults aged 20–55 years are eligible to participate in
the study. In years 1 and 5, we will select a quota sample
of 50 houses per shehia according to a method suggested
by Winkler et al. [59]. For this purpose, a gyro with a
marked arrow-star (equal to the number of field inter-
viewers in a team) pointing into different directions will
be spun on a central point in the shehia. Subsequently,
each interviewer will count the households to the edge
of the shehia following a path in direction of the arrow.
On return to the centre point, the number of house-
holds in that direction will be reported and the inter-
viewer will state a number within the range of counted
households. This number will be compared to a list with
computer-generated random numbers created for each
shehia. The random number corresponding to the num-
ber stated by the interviewer will assign where to start
the first questionnaire interview. Proximity sampling will
then be pursued with interviewers moving from one
household to the next nearest household until 50 house-
holds are covered. People sharing the same kitchen or
pot will define a household. If more than one of the
present household members is eligible to participate, we
will use a “drawing cards” approach for randomly select-
ing only one of the members to participate in the study.
We plan to collect 4,500 urine samples and question-
naire data from adults aged 20–55 years in years 1 and 5
on each of the two islands.
Data collection
Recruitment of participants and collection of specimen
and questionnaire data
The community leaders and headmasters of the selected
shehias and primary schools will be informed about the
aims and procedures of the study. Each year, in the
selected schools, the teachers will be informed about the
forthcoming activities. The study will be explained in lay
terms to the children and they will be asked for their
oral assent to participate. Children will be selected
according to the eligibility criteria and randomization as
described above. Name, sex, age, school grade and vil-
lage and shehia of residency of the selected children will
be recorded and the children will be provided with an
information and consent form, the latter to be signed by
their parents or legal guardians and to be returned the
following day. On that day, children who submitted a
signed consent form will be provided with a plastic con-
tainer (120 ml) labelled with the individual’s ID, for sub-
sequent urine collection on the spot between 10 AM
and 12 AM. From the selected children from the first-
year at school, in addition to a urine sample, a finger-
prick blood sample will be collected in small tubes (BD
Microtainer, Ref.: 365967; BD, Oxford, UK) labelled with
the individual’s ID and stored on ice after clotting.
Figure 2 Assignment of communities (shehias) to control interventions aiming to eliminate urogenital schistosomiasis in Zanzibar. On
both, Unguja and Pemba islands, 45 shehias were randomly assigned to one of three intervention arms: 15 shehias on each island will receive
praziquantel administration as implemented according to the National Plan of the Zanzibar government, 15 shehias will be targeted by behaviour
change interventions in addition to praziquantel administration and 15 shehias will receive snail control in addition to praziquantel
administration.
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about the purpose and procedures of the study and
invited to inform the community about the forthcoming
visits of households. The sheha will be interviewed in Ki-
swahili with a “village inventory form” and asked a set of
questions on the demographic characteristics of his she-
hia. In addition to general information, data on occupa-
tion of the population closely related to water contact,
on health facilities and available drugs, on water contact
sites, on availability and use of water sources and
sanitary facilities will be collected.
While visiting the households selected as described
above, the study procedure will be explained to the
present household members in Kiswahili and they will
be asked for their oral assent to participate. The selected
household member will be invited to sign a writteninformed consent form, given a urine collection con-
tainer labelled with a unique ID and asked to provide a
urine sample on the spot, ideally produced between 10
AM and 2 PM of the same day. Additionally, the partici-
pant’s ID, sex, age, occupation, place of birth, time of
residency in the respective shehia and sanitary behaviour
will be recorded using a pre-tested questionnaire admi-
nistered in Kiswahili.
Laboratory procedures to assess S. haematobium infection
in humans
In the laboratory, each urine sample will be screened for
visual blood (macrohaematuria) and for microhaema-
turia using reagent strips (Haemastix; Siemens Health-
care Diagnostics GmbH, Eschborn, Germany). When
tested visually, the colour of the urine will be coded
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(1, 2, 3, 4, 5, 6); the colorimetric test of the reagent
strip for microhaematuria will be recorded semi-
quantitatively (0 = negative, 1 = +, 2 = ++, 3 = +++, 4 =
trace). Additionally, urine samples will be vigorously
shaken and 10 ml of each sample will be filtered using a
plastic syringe with a filter-holder containing a 13 mm
polycarbonate filter (Sterlitech, Kent, WA, USA) [60].
All S. haematobium eggs present on the filter will be
counted under a microscope by experienced laboratory
technicians and exact egg counts will be recorded for
each individual.
From a subset of fresh urine samples with microhae-
maturia according to positive reagent strip tests, S. hae-
matobium eggs will be hatched and miracidia collected
and stored on Whatman FTA indicator cards (Whatman
plc, Maidstone, UK) [61] for population genetic studies
layered onto the current study to evaluate the impact of
the interventions on the genetic diversity and population
structure of the schistosomes in the shehias.
Additionally, on each survey day in years 1 and 5,
from every 10th of the collected urines of sufficient
amount after the urine filtration has been performed,
10 ml will be transferred into 15 ml Falcon tubes, la-
belled with the ID of the respective participant and
stored for future use at −20°C at HCLU/PHL-IdC. The
frozen samples will be examined for S. haematobium
infections using novel sub-microscopic diagnostic
approaches (i.e. PCR or ELISA) evaluated either within
SCORE studies or by external partners who have yet to
be identified.
The clotted finger-prick blood samples will be centri-
fuged at 6,000 g for 10 min immediately after arrival at
HCLU/PHL-IdC. The sera will be transferred into
semi-skirted 96 well plates (maximum 250 μl), labelled
and stored at −80°C at PHL-IdC pending further ana-
lyses. Antibody levels against S. haematobium antigen
will be tested using ELISA, following the manufac-
turer’s instructions or using newly developed multi-
plexing assays.
For quality control, microscope slides with the filter
containing potential S. haematobium eggs will be cov-
ered with cellophane soaked in glycerol and stored in
slide storing boxes that are kept at room temperature.
After each survey, 10% of the slides of each technician
will be re-read by external senior laboratory techn-
icians by adding a drop of Lugol’s solution on the
hydrophilic cellophane. The number of S. haematobium
eggs will be recorded and compared with the original egg
counts. In the case of significant discrepancies between
the original and re-read slides (false negatives, false posi-
tives, egg counts resulting in a different infection intensity
category) that exceed a defined threshold, all stored slides
of the respective technician will be re-examined.Monitoring of snail populations and infection level
Preceding each round of preventive chemotherapy,
transmission sites at open water bodies where humans
have regular contact with water (identified on maps and
by consulting community members and children) in the
15 selected shehias on both islands will be treated with
niclosamide 70% WP. The number of freshwater bodies
treated, their kind, size and exact location will be
recorded. The amount of niclosamide 70% WP used will
be recorded after each intervention. Before treating the
water bodies, snail densities will be assessed at each site.
For this purpose, a sample area of 15 m2 will be mea-
sured and surveyed for any snails for 15 min by two
trained staff. All snails will be deposited into a basin and
all organisms alive and dead in the collection tube will
be counted and recorded. Snails will be classified to spe-
cies level. Once the number and species of snails and
the genus of the other organisms have been recorded, all
organisms, except B. globosus, will be returned and
evenly distributed to their original collection sites.
Temperature, pH, salinity and conductivity of the water
will be measured and recorded at each of the sites, on
all survey and sample days using standard protocols and
forms. All collection sites will be located using a hand-
held global positioning system (GPS) device (Garmin
GPSMap 62, Garmin (Europe) Ltd; Southhampton, UK).
B. globosus snails will be transferred to HCLU in
Unguja and PHL-IdC in Pemba to determine whether
they are infected with S. haematobium. Snails will be
investigated for parasitic infection using the shedding
method. For this purpose the snails will placed individu-
ally in flat-bottomed glass vials (height: 7.5 cm, diameter:
2.5 cm) containing dechlorinated water, and exposed to
indirect sunlight for a maximum duration of 4 hours
[62]. Cercariae shedding will be observed using a dissec-
tion microscope. Snails that do not shed cercariae on
the first sunlight exposure will be re-exposed on the sec-
ond day. Based on their morphology, cercariae will be
categorized either as those of S. haematobium or those
of other trematodes (non-S. haematobium cercariae)
[63]. S. haematobium cercariae will be collected using a
pipette and placed on Whatman FTA cards for future
molecular analysis. All collected snails will be preserved
in small glass tubes containing 100% ethanol, which will
be deposited in the schistosomiasis repository (SCAN;
http://www.nhm.ac.uk/research-curation/collections/cur-
ation-groups/scan/index.html) held at NHM in London,
and made available for future investigations as needed.
Assessment of behaviour change
The impact of interventions on the behaviour of people
living in the targeted 15 shehias in the behaviour change
study arm on each island will be assessed in qualitative
baseline and annual follow-up studies. In-depth
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with young and older schoolchildren, teachers, parents
and community leaders will be conducted in Kiswahili
by trained members of the Zanzibar NTD Programme.
The content of each FGD and IDI will be recorded and
transcribed into English and analyzed through a modified
grounded theory approach. Additionally, pre-tested struc-
tured observation checklists will be used to capture critical
observations of the same behaviours in households and
public venues. Brief questionnaires, based upon behav-
ioural theory constructs, will be administered to measure
behavioural determinants associated with the intervention
implementation process and to assess its impact on S. hae-
matobium infections in schoolchildren and communities.
Collection of additional data relevant for the study
outcomes
Baseline data on the 90 selected shehias will be collected
from the existing health management information system
(HMIS), the Office of the Chief Government Statistician
Zanzibar, available aerial photographs, and by consulting
the local authorities (shehas and school headmasters) and
key informants. This baseline information will include
data on the area of the shehias (in km2), number of inhabi-
tants, number and size of primary and secondary schools,
number of public and private health centres, number of
MCH facilities, water sources for private and domestic use
(e.g. piped water, wells, rivers and ponds), sanitation cover-
age (e.g. number of pit latrines, ventilated improved pit
latrines, flush toilets), immigration and main income
source of the population, mainly covered within the village
inventory form. To track multiple factors that could affect
study outcomes, shehas will be interviewed on an annual
basis. In addition to direct village inventories, we will
gather and store reports from non-governmental organisa-
tions (NGOs) involved in water and sanitation as well as
other health-related projects and be in regular contact and
exchange with ZAWA to track their activities.
Praziquantel treatments in community health centres
will be recorded and the data transferred to the HMIS of
the MoH. In relation to preventive chemotherapy adminis-
tration according to the National Plan, the Zanzibar MoH
will collect data on treatment coverage, use of praziquantel
from primary health care units (PHCUs) and treatment of
pregnant women in MCH facilities. Costs incurred for all
activities will be recorded and used to estimate the cost-
effectiveness of the different intervention arms.
Data management and analysis
Quantitative data from laboratory examinations, question-
naires and snail records will be entered in Microsoft Excel
version 10.0 (2002 Microsoft Corporation) or EpiInfo ver-
sion 3.5.1 (Centers for Disease Control and Prevention;
Atlanta, GA, USA) by local staff in Zanzibar. Statisticalanalyses will be carried out with STATA version 10
(StataCorp.; College Station, TX, USA). Descriptive and
regression analyses will be conducted to evaluate the
effectiveness of the interventions under study, including
evaluation of cost and cost-effectiveness. In addition,
spatial analysis will be conducted to identify clusters and
spatially defined factors that may be modifying outcomes.
For each year, S. haematobium prevalence and infection
intensity data will be calculated. The results from the dif-
ferent study arms will be compared on an annual basis,
after 2 years of intervention and at the end of the 4-year
intervention period.
For the assessment of effectiveness of behaviour change
interventions, FGDs and IDIs will be transcribed verbatim,
translated into English by bilingual research assistants and
entered as Microsoft Word documents into Atlas-ti ver-
sion 6.0 (Software Development GmbH; Berlin, Germany)
to facilitate text searching, data coding and analysis. Open,
axial and selective coding will be used to analyse the tran-
scribed narratives. Open coding and a word-by-word
analysis will be used to identify, name and categorize
explanations and descriptions of the day-to-day reality of
participants as related to schistosomiasis and other water-
related issues. Structured observations will be summarised
and descriptive open-ended questions analysed in the
same manner for the FGDs and IDIs narratives.
Data storage and handling
All original data records will remain within the office of
the HCLU or PHL-IdC of the MoH Zanzibar. Electronic
data files will be transferred to the NHM in London and
Swiss TPH in Basel and original and cleaned data will be
stored in a password-protected folder accessible for all
investigators. Name-linked information on participants
will remain confidential and be shared only by the study
team. Unique identifiers will be used for data records,
transcripts and computer-based software data manage-
ment. When discussing or showing the results of ana-
lyses in public venues, the information will always be
reported at an aggregate level so that individual partici-
pants cannot be identified.
Protocol review and ethical clearance
The study protocol summarised here was reviewed by the
SCORE secretariat consisting of several scientists with
long-term experience in the epidemiology and control of
schistosomiasis before it was submitted to and accepted
by (i) the Zanzibar Medical Research Ethical Committee
(ZAMREC), (ii) the “Ethikkomission beider Basel” (EKBB)
in Switzerland, and (iii) the institutional review board of
the University of Georgia (IRB UGA). The trial has been
registered at the International Standard Randomised Con-
trolled Trial Number Register (ISRCTN48837681; http://
www.controlled-trials.com/ISRCTN48837681).
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will be informed about the purpose and procedures of
the study and the respective study segment and asked to
submit a written informed consent prior to collection of
urine or finger-prick blood samples, or the collection of
questionnaire, FGD or IDI data. The obtained informa-
tion will be treated with strict confidentiality and data
made anonymous before analysis.Discussion
In November 2011, the Secretariat of the WHO consid-
ered that elimination of schistosomiasis “is feasible in all
epidemiological settings, provided that there is strong
political commitment to the goal, supplies of anthel-
minthic medicines for preventive chemotherapy are ad-
equate, and support is provided by the international
community” [64]. Further, the Executive Board called
“on all countries endemic for schistosomiasis to intensify
control interventions and strengthen surveillance, with
the aim of eliminating the disease” [64]. A few months
later, in May 2012, the 65th World Health Assembly
announced that schistosomiasis elimination campaigns
should be initiated where appropriate [65].
The islands of Zanzibar are meeting the requirements
specified by the secretariat, rendering the archipelago a
suitable candidate for schistosomiasis elimination. Control
of schistosomiasis has a long-term history on Unguja and
Pemba [18,19,23,35,66,67]. Elimination of urogenital schis-
tosomiasis on the islands of Zanzibar is a health priority,
endorsed by the President, and the Zanzibar MoH is com-
mitted to fulfil the National Plan [36]. The MoH and the
Zanzibar NTD Programme have backing from important
and influential partners such as WHO and SCI, which will
strongly support the control and elimination efforts on
both islands by donating praziquantel and funding treat-
ment implementation costs, respectively. The rigid bound-
aries of the islands, the strong public health system and a
number of successful previous campaigns against malaria
[68], cholera [38], lymphatic filariasis [69], soil-transmitted
helminthiasis [70,71] and schistosomiasis [18,37] have sen-
sitized the population [72]. Huge steps towards elimination
of lymphatic filariasis and malaria in Zanzibar have been
made [68,69] and the elimination of urogenital schistosom-
iasis in Unguja seems now an achievable goal [29,73].
However, a broad consensus has been reached in the
international community that long-term commitment by
influential partners and efforts going beyond preventive
chemotherapy are needed to achieve elimination [29,74,75].
Indeed, examples of countries having achieved schistosom-
iasis elimination show that preventive chemotherapy must
be fully integrated with other tools of transmission control
such as mollusciciding against snail intermediate hosts,
changing behaviour to avoid the contamination of waterbodies and prevent (re-)infection and improving water and
sanitation [29,75-77].
The study on urogenital schistosomiasis elimination in
Zanzibar that we describe here will contribute to identi-
fying what, in addition to preventive chemotherapy,
needs to be done to prevent, control and ultimately
eliminate schistosomiasis, and to draw lessons for
current and future schistosomiasis elimination pro-
grammes. It will provide important information for the
Zanzibar NTD Programme and for other endemic areas
in Africa and elsewhere that aim to eliminate schisto-
somiasis, and particularly urogenital schistosomiasis.
Based on the findings and outcomes of the proposed
study, and in close collaboration with WHO and other
partners, new guidelines for schistosomiasis control pro-
grammes progressing from morbidity control to trans-
mission control/local elimination may be developed.
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